Olumiant 2 mg Tablet

Product Description

Olumiant 2 mg Tablet is a targeted therapy classified as a Janus kinase (JAK) inhibitor, designed to alleviate pain, stiffness, and swelling associated with moderate to severe rheumatoid arthritis in adults who have not experienced sufficient relief from one or more tumor necrosis factor (TNF) antagonists. By inhibiting the activity of the Janus kinase enzyme, Olumiant helps to reduce inflammation and slows the progression of joint and bone damage, improving overall joint function. In addition to its primary use for rheumatoid arthritis, Olumiant is also indicated for adults hospitalized with COVID-19 who require supplemental oxygen or respiratory assistance, showcasing its versatility in critical care settings. However, its essential to be aware of potential risks, including serious infections, blood clots, and changes in blood cell counts, necessitating regular monitoring by healthcare professionals. As a prescription medication, Olumiant should be taken under the guidance of a qualified healthcare provider to ensure safe and effective use. With its unique mechanism of action, Olumiant offers a valuable option for patients seeking relief from debilitating arthritis symptoms or facing severe COVID-19 complications.